Searched for
ALEMBIC PHARMA Q3 NET PROFIT
Logistics market can’t support more than three players, further consolidation likely: Delhivery's Sahil BaruaDelhivery is entering its next phase of growth, with CEO Sahil Barua betting on high-growth segments while continuing to push hard to expan...- Stocks in news: Waaree Energies, Kotak Bank, HDFC Bank, Strides Pharma, Persistent SystemsIndian markets showed volatility, ending nearly flat despite positive signals. Analysts note Nifty faces resistance from key moving average...
- Alembic Pharma gets USFDA nod for generic influenza treatment drugAlembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. Th...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- Cooling crude prices drive weekly gains; Street expects Q2 earnings recoveryIndian stock markets closed slightly higher on Thursday, marking a third consecutive week of gains, buoyed by falling crude oil prices. The...
- Buy, Sell or Hold: Morgan Stanley remains overweight on Trent; Citi maintains buy on BELBrokerages are bullish on select retail, defence, and auto stocks, citing strong growth prospects. Morgan Stanley backs Trent's aggressive ...
- Tech-Led global selloff, Fed rate fears weigh on Indian equitiesIndian stock markets experienced their sharpest single-day drop in nearly a month, mirroring a global tech sell-off. The Nifty 50 and BSE S...
- Honasa Consumer to acquire majority stake in Fluence Pharma at Rs 135-crore valuationHonasa Consumer has secured a majority stake in Mumbai's hair therapy brand Fluence Pharma for Rs 135 crore. This move marks the company's ...
- Meesho shares rise 2% as Citi initiates coverage with Buy rating. Here's whyInternational brokerage Citi initiated coverage on Meesho with a 'Buy' rating, setting a target price of Rs 210 and anticipating a 23% upsi...
- Vedanta shares fall 6% after Rs 2,149 crore block deal; promoter Twin Star likely sellerVedanta's stock experienced a significant dip, dropping up to 6% from its intraday peak of Rs 287. This decline followed media speculation ...
- Bharat Electronics shares in focus after defence PSU wins orders worth Rs 1,081 croreBharat Electronics shares are in focus following a significant Rs 1,081 crore order win, adding to previous gains. The defence PSU reported...
- Cochin Shipyard shares fall 3% amid buzz around OFS at 8% discountCochin Shipyard shares dipped Monday following reports of a potential government Offer for Sale (OFS) at a discount. The government, aiming...
- Tata Capital shares slip 3% after stock rallies 17% in one week to lifetime high. What’s ahead?Tata Capital shares saw a dip on Monday following a significant rally that propelled them to an all-time high last week. Despite a recent s...
- Cipla shares jump 4% as Citi puts stock on 90-day catalyst watch. What's driving the optimism?Cipla's stock surged following Citi's 'Buy' rating and a 90-day Positive Catalyst Watch. The brokerage anticipates growth from potential US...
- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- India bans 16 fixed-dose drug combinations over safety concernsIn a significant public health initiative, the ban on 16 fixed-dose drug combinations, including various antibiotics and topical formulatio...
- RIL AGM: Reliance Industries shares fall 2% amid Mukesh Ambani's big announcements at 49th AGMReliance Industries shares dipped nearly 2% despite Chairman Mukesh Ambani announcing the approved Jio DRHP for a $4 billion IPO. The compa...
- Alembic Pharma gets tentative nod from USFDA for generic cancer drugAlembic Pharmaceuticals has secured tentative approval from the USFDA for its generic Binimetinib tablets. This marks a significant step fo...
- ICICI Prudential AMC shares fall 2% as IPO lock-in expiry frees up Rs 1.2 lakh crore stake for tradeICICI Prudential AMC shares dropped 2% to Rs 513 as 34.4 crore shares became eligible for trade post IPO lock-in expiry. The company's stoc...
- Yes Bank shares jump 16% in 5 days, hit fresh 52-week high. What lies ahead?Yes Bank shares climbed to a fresh 52-week high, extending gains over five sessions and adding Rs 8,662 crore to market value. The rally fo...
Load More
